Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119119158A reveals a novel plant-derived route for ursodeoxycholic acid. Achieve high purity and cost reduction in API manufacturing with scalable bio-hybrid synthesis.
Patent CN105330715B enables high-purity TUDCA synthesis with improved supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104804055A details silylation purification for 7-ketolithocholic acid ensuring high purity UDCA intermediates and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105294809A reveals a novel two-step synthesis for high-purity Tauroursodeoxycholic Acid, eliminating toxic impurities and ensuring scalable pharmaceutical intermediate manufacturing.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Novel patent CN119462811A offers high-yield ursodeoxycholic acid synthesis with reduced steps and enhanced safety for reliable pharmaceutical intermediate supply chains.
Patent CN113336818A details a high-yield synthesis of alpha-murine cholic acid from hyocholic acid, offering superior purity and scalable manufacturing for pharmaceutical research.
Patent CN117229342A reveals advanced glycocholic acid purification reducing solvent residue significantly for pharmaceutical intermediate manufacturing supply chains.
Patent CN115181150A details a green synthesis of UDCA from phytosterol derivatives, offering high yield and reduced chromium pollution for reliable API intermediate supply.
Patent CN111328332A details a novel synthetic route for cholic and deoxycholic acid from plant-derived DHEA, ensuring high purity and eliminating animal-derived impurities for reliable supply chains.
Novel synthesis method for glycocholic acid PEG derivatives improves solubility and yield. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN109402212B reveals a novel fusion enzyme method for TUDCA production, offering significant cost reduction in bile acid manufacturing and reliable supply chain scalability.
Patent CN107383139A reveals novel protecting groups for Obeticholic acid intermediates improving purification yield and supply chain stability for pharmaceutical manufacturing.
Patent CN115611961A reveals a mild elimination route for Cholic Acid Intermediate A2, enabling virus-free API production with scalable supply chain advantages.
Patent CN115611961A details a novel chemical synthesis for Cholic Acid Intermediate A2, offering a virus-free alternative to animal extraction with scalable manufacturing capabilities.
Advanced synthesis of Obeticholic Acid intermediates via NBS oxidation and Wittig reaction. Cost-effective, scalable API manufacturing solutions for global pharma.
Novel silane-protection route for Obeticholic Acid reduces impurities and enhances scalability for pharmaceutical manufacturing.
Patent CN119119158B reveals a novel plant-derived synthesis route for ursodeoxycholic acid offering significant supply chain stability and cost reduction advantages.